InsidersTradesSigma
Mannatech INC Stock: price and insider trades · United States · SEC (Form 4)
Track the Mannatech INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Mannatech INC has published 56 public disclosures. Market capitalisation: €11m. The latest transaction was reported on 6 January 2025 (Attribution). Among the most active insiders: Robbins Kevin Andrew. Every trade is free.
56
Insider Decl.
0
Thresholds
€114,366
1 ops.
Buy Volume
€418,226
13 ops.
Sell Volume
45Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,330 of 26,211 companies
26.4
score / 100
Value3
Quality50
FCF yld-39%
Earn yld-138%
EV/EBITDA·
ROE·
Gross mgn75%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 January 2025
Declarations56 total
2,686 shares@ US$14.8939.9% of flowCommon stock, par value $0.0001SEC:0001056358-25-000002:0
2,686 shares@ US$14.8912.1% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-25-000011:0
2,686 shares@ US$14.8912.4% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-25-000012:0
2,686 shares@ US$14.895.8% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-25-000010:0
2,686 shares@ US$14.8913.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001056358-25-000004:0
2,686 shares@ US$14.8914.4% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-25-000013:0
16,288 shares@ US$7.7538.5% of flowCommon Stock, par value $0.0001 per shareSEC:0001056358-24-000070:0
Ideal exit: 6 Jun 2025 (T+270)
16,288 shares@ US$7.7535.9% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000072:0
4,932 shares@ US$8.1113.5% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000068:0
1,012 shares@ US$7.602.2% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000046:0
8,187 shares@ US$9.1686.5% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000014:0
4,932 shares@ US$8.115.4% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000008:0
4,932 shares@ US$8.1111.4% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000006:0
4,932 shares@ US$8.1137.5% of flowCommon stock, par value $0.0001SEC:0001056358-24-000009:0
4,932 shares@ US$8.1113.5% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-24-000010:0
4,932 shares@ US$8.1112.2% of flowCommon Stock, par value $0.0001 per shareSEC:0001056358-24-000007:0
1,000 shares@ US$12.404.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001056358-23-000061:0
1,217 shares@ US$12.824.5% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-23-000059:0
154 shares@ US$12.890.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001056358-23-000051:0
2,000 shares@ US$5.7213.5% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-23-000014:0
1,338 shares@ US$17.4322.6% of flowCommon stock, par value $0.0001SEC:0001056358-23-000002:0
2,294 shares@ US$17.4314.0% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-23-000008:0
2,294 shares@ US$17.4312.0% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-23-000006:0
2,294 shares@ US$17.4312.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001056358-23-000004:0
2,294 shares@ US$17.435.6% of flowCommon Stock Par Value $0.0001 Per ShareSEC:0001056358-23-000012:0
25 of 56 declarations
About Mannatech INC
Mannatech, Incorporated (ticker: MTEX) is a U.S.-listed small-cap company traded on the NASDAQ Capital Market in the United States, operating in the health and wellness industry. Founded in 1993 and headquartered in Flower Mound, Texas, the company develops and markets proprietary nutritional supplements, topical skin-care and anti-aging products, and weight-management and fitness products. Its business model is rooted in direct selling and an independent distributor network, placing it closer to a network-marketing wellness company than to a traditional pharmaceutical manufacturer. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1056358/000105635825000018/mtex-20241231.htm?utm_source=openai)) Historically, Mannatech has positioned itself as a pioneer of “glyconutrition,” a plant-based nutrition concept centered on ingredients intended to support cellular nutrition. The company highlights product families such as Ambrotose and a broader portfolio aimed at nutrition, immune health, skincare, and weight management. This gives Mannatech a distinct brand identity, but it also means the company is highly dependent on consumer trust, the perceived credibility of its product claims, and the effectiveness of its distributor ecosystem. ([us.mannatech.com](https://us.mannatech.com/products/?utm_source=openai)) From a competitive standpoint, Mannatech operates in a crowded, fragmented market where supplement brands, beauty-focused wellness companies, and direct-selling peers all compete for recurring customers and active distributors. The company’s moat is not based on scale or cutting-edge IP, but on brand loyalty, product differentiation, and network engagement. Management discloses sales across three geographic regions: the Americas, EMEA, and Asia/Pacific, showing an international footprint despite the company’s relatively modest size. Its headquarters and corporate base remain firmly anchored in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1056358/000105635825000018/mtex-20241231.htm?utm_source=openai)) Recent developments suggest continued operational consolidation and disciplined portfolio management. In the second quarter of 2024, Mannatech liquidated its Sweden entity, and its investor-relations materials show ongoing SEC reporting and a 2025 quarterly reporting cycle. The company’s recent filings and insider-activity coverage reinforce that MTEX is closely watched by microcap investors and market participants following SEC Form 4 disclosures. For investors, Mannatech is best viewed as a niche U.S. wellness platform with a long operating history, a recognizable product set, and an international sales base, but also meaningful exposure to regulatory, reputational, and channel-execution risks common in the dietary supplement sector. ([ir.mannatech.com](https://ir.mannatech.com/overview/default.aspx?utm_source=openai))
